【Home and End-of-life Care in the Czech Republic】 Czech home-based palliative care takes many forms — hospital-affiliated, municipal, NGO-run, private — but all share a strong reliance on backup from larger hospitals. The ability to admit a patient quickly during sudden deterioration is treated as a precondition for home care, and expanding public insurance reimbursement has strengthened its financial base. Although advance directives are legally binding, clinicians often face the difficulty of "reconciling intentions written down years ago with what is genuinely best at this moment." Formal requirements — notarisation, physician's written explanation — act as a real barrier, and few patients arrive with a valid directive in hand; much still depends on dialogue with family and close people. When close people disagree, decisions are often left to the clinical team's judgment — strikingly similar to Japanese practice. Further dilemmas arise when a patient later expresses a different wish — for example, "I want to live a little longer" as dementia advances. The law allows revocation at any time, but judging whether the patient retains the capacity to revoke is itself a clinical question. What stands out most in comparison with Japan is that Czech end-of-life decisions tend to be treated more clearly as something belonging to the individual patient. The advance directive system rests on an individualist premise; families support and represent the patient's will rather than co-deciding it. While families still take on much of the caregiving, the sense that "the family must shoulder this alone" feels less weighty than in Japan. The starting point is closer to "this is how I want to live, and how I want to die" than to "I'll give up treatment so as not to burden my family." That the center of gravity rests so clearly on the patient is, to me, one of the most striking cultural differences between the two countries.【Home and End-of-life Care in Japan】 Home-based care in Japan is typically delivered through local clinics and home-care support clinics, working with visiting nurse stations, pharmacies, and long-term care services. The system relies heavily on the family-physician tradition, so quality and availability vary noticeably between regions and institutions. In decision-making, the relative weakness of formal surrogate frameworks means family consensus tends to become the de facto deciding factor — sometimes called "over-emphasis on family consensus." The spread of ACP has gradually nurtured ongoing conversation among patients, families, and clinicians, recognising that wishes are not fixed but evolving. As long as a patient retains capacity, their current wish takes precedence; once capacity is lost, however, families may change course, leaving clinicians caught between the family's present position and the patient's earlier wishes. Behind these tensions lies a powerful cultural force: the wish "not to burden one's family." MHLW surveys consistently rank this among the top reasons for end-of-life preferences, at strikingly higher rates than in international comparisons. ACP, meant to begin with the patient's own values, can instead become an expression of self-restraint — "for my family's sake, I have no choice." A patient who initially wished for a home death may later say, "If staying home means burdening my family, I'd rather be in a hospital." Untangling the patient's true voice from the voice of consideration for family becomes a delicate task — and is, I believe, what makes Japanese ACP both especially difficult and especially rich.Clinical Practice - The Patient's Will and the Family's VoiceThe Data - Where People Die12
元のページ ../index.html#13